Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated with Daptomycin: Is it Time to Change the Breakpoint?
- Bhavarth S. Shukla
- , Samuel Shelburne
- , Katherine Reyes
- , Mini Kamboj
- , Jessica D. Lewis
- , Sandra L. Rincon
- , Jinnethe Reyes
- , Lina P. Carvajal
- , Diana Panesso
- , Costi D. Sifri
- , Marcus J. Zervos
- , Eric G. Pamer
- , Truc T. Tran
- , Javier Adachi
- , Jose M. Munita
- , Rodrigo Hasbun
- , Cesar A. Arias
- Medical School at Houston
- University of Texas Health Science Center at Houston
- Department of Infectious Diseases
- Genomic Medicine
- MD Anderson Cancer Center
- Department of Internal Medicine
- Henry Ford Health System
- Memorial Sloan-Kettering Cancer Center
- Division of Infectious Diseases and International Health
- University of Virginia
- Universidad El Bosque
- Molecular Genetics and Antimicrobial Resistance Unit
- Wayne State University
- Universidad del Desarrollo
Producción: Contribución a una revista › Artículo › revisión exhaustiva
100
Citas
(Scopus)